SCHEMBL5907286

SCHEMBL5907286

Fc1ccc(-c2ccc(-n3ncc(CN4CCOCC4)c3-c3ccccc3F)cc2)c(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A13 Q16696 1/20 0.44
SSTR5 P35346 1/20 0.42
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
ALOX5AP P20292 7/20 0.40
FEN1 P39748 7/20 0.40
SLC2A1 P11166 1/20 0.38
S1PR1 P21453 1/20 0.38
LRRK2 Q5S007 1/20 0.38
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
TYK2 P29597 1/20 0.38
JAK3 P52333 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
KCNH2 Q12809 1/20 0.38
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5907245 0.93 CYP2A13 (0.44) CYP2A13SSTR5ADORA2AADORA1ALOX5AP
SCHEMBL5907238 0.93 CYP2A13 (0.50) CYP2A13SSTR5ADORA2AADORA1ALOX5AP
SCHEMBL5730793 0.88 CYP2A13 (0.45) CYP2A13SSTR5ADORA2AADORA1ALOX5AP
SCHEMBL5907262 0.86 CYP2A13 (0.45) CYP2A13SSTR5ADORA2AADORA1SLC2A1
SCHEMBL5907325 0.86 CYP2A13 (0.45) CYP2A13SSTR5ADORA2AADORA1ALOX5AP
SCHEMBL5907306 0.86 CYP2A13 (0.45) CYP2A13SSTR5ADORA2AADORA1ALOX5AP
SCHEMBL5907335 0.86 CYP2A13 (0.47) CYP2A13SSTR5ADORA2AADORA1ALOX5AP
SCHEMBL5731887 0.86 JAK2 (0.45) CYP2A13SLC2A1JAK2JAK1TYK2
SCHEMBL5731706 0.85 CYP2A13 (0.46) CYP2A13SSTR5ADORA2AADORA1SLC2A1
SCHEMBL5730763 0.85 KMT2A (0.46) CYP2A13SSTR5SLC2A1CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264419-A1 Substituted pyrazoles MERCK PATENT GMBH (DE) 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264419-A1 Substituted pyrazoles HTR3A, HTR1A, HTR1D CYP2A13 659/4885SSTR5 97/4885ADORA2A 170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.